Andrew Hopkins

Exscientia

Professor Andrew Hopkins, 47, spent a decade with Pfizer before launching Exscientia as a spinout from Dundee University in 2012. The company’s artificial intelligence technology is used to develop drugs. It has signed multimillion-pound research deals with Glaxo Smith Kline and Sanofi.

Request a Test Drive, a Quote or More Information


GET IN TOUCH